Chewy Gets FDA Warning About Unapproved Antimicrobial Animal Drugs
By Dean Seal
Chewy and eight other manufacturers and distributors of antimicrobial animal drugs have received warning letters from the Food and Drug Administration telling them that those medicines are unapproved and misbranded.
The agency said on Thursday that it's concerned that using the products, which contain antimicrobials that are important in human medicine, without medical oversight contributes to the development of antimicrobial resistance.
The FDA said it hasn't verified the safety or effectiveness of the products as part of an animal drug review process or facility inspections, and that the products are being illegally marketed over the counter. The products are marketed and labeled for minor species such as aquarium fish and pet birds, and contain antimicrobials including amoxicillin and penicillin.
Representatives for Chewy didn't immediately respond to a request for comment.
Among the other companies that received FDA warning letters were Kraft Drug and California Veterinary Supply.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
December 14, 2023 11:19 ET (16:19 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth